Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014–2016)

Frequency and patterns of first- and second-line drug resistance-conferring mutations in Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients in a cross-sectional study in Tigray Region, Ethiopia

Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year’s review

Abstract Background Second-line drug resistance (SLD) among tub

Drug Resistance Among Adolescents and Young Adults with Virologic Failure of First-Line Antiretroviral Therapy and Response to Second-Line Treatment

Barriers to sustainable virologic suppression (VS) of HIV-infected adolescents and young adults incl

Major protease inhibitor drug resistance mutations among patients with virological failure on second-line antiretroviral therapy in Zimbabwe: a retrospective cross-sectional study

Abstract Background Virological fail

HIV drug resistance and third line treatment outcomes in patients failing: Protease Inhibitor based second-line antiretroviral therapy in Zimbabwe

Introduction: We set out to assess the distribution of HIV drug resistance mutations and their risk

Detection of Second Line Drug Resistant Mycobacterium tuberculosis among Patients Attending National Tuberculosis and Leprosy Training Center Zaria, Nigeria

Tuberculosis (TB) is an infectious disease cause by Mycobacterium tuberculosis and it remain one of